The biotech Gilead Sciences has been the best-performing healthcare stock in the S&P 500 by far over the past 12 months. Its ...

Gilead Sciences releases its first-quarter results after Thursday's closing bell. Here's a look at the details from the report.

Gilead’s HIV drug business grew while its Covid drug sales tanked in the first quarter of 2025, as the company recorded the ...

Looking ahead, Gilead Sciences cut its full-year earnings outlook to $5.65 to $6.05 a share from a prior range of $5.95 to $6.35 a share. Analysts had been expecting full-year earnings of $6.22. The ...

(GILD) on Thursday reported first-quarter earnings of $1.32 billion. The Foster City, California-based company said it had net income of $1.04 per share. Earnings, adjusted for costs related to ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

The Mount Gilead softball team jumped out to a first-inning lead over visiting East Knox on Wednesday, but couldn’t hold onto ...

Gilead Sciences on Thursday reported slightly higher-than-expected quarterly earnings on flat revenue, as higher sales of ...

Margaret Atwood's dystopian book The Handmaid's Tale was published in 1985 and the main storyline revolves around Offred (June).

The Scots got doubles by Zach Church and Gavin Wiggand in the win, while Jayden Collins finished with a pair of singles. Church also went six innings to earn the win. He and Collins combined to strike ...

The cast of The Handmaid's Tale visits WIRED to answer the 50 most searched for questions about the show as it enters its ...